Clinical Trial

Evaluation of the Impact of Taking American Ginseng for 8 Weeks on Fatigue in Patients Treated for Localized Breast or Gynecological Cancer

Study acronym: QISEIN
Recruiting
View on ClinicalTrials.gov →
Summary
This is a multicenter randomized trial in breast cancer patients reporting cancer-related fatigue to evaluate the efficacy and safety of Qiseng® based on extract of American ginseng combined with vitamin C from extract of Camu Camu berries
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2022-02-11; most recent amendment 2024-09-30.
Status change: Not Yet Recruiting → Recruiting 2022-09-27
Trial Details
NCT Number NCT05241405
Lead Sponsor Centre Francois Baclesse
Collaborators: NATSUCA laboratory, Groupement Interrégional de Recherche Clinique et d'Innovation
Conditions Breast Cancer, Fatigue
Enrollment 354 participants
Start Date 2022-09-27
Primary Completion 2027-09 (estimated)
Study Completion 2027-09 (estimated)
Updated on ClinicalTrials.gov 2024-10-01